common.study.topics.clinical

Testing Experimental Treatment for Advanced Solid Tumors

common.study.values.description

A Study of LY3435151 in Participants With Solid Tumors

The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - LY3435151

Administered IV

Drug - Pembrolizumab

Administered IV

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Phase 1a/1b Study of LY3435151 Administered to Patients With Advanced Solid Tumors

common.study.values.clinical-trial-id

NCT04099277

participant.views.study.view.id

azpkYd